Severe pediatric sepsis

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 2, 2012, Pages 111-114

  Nadel, Simon ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

pathophysiology; pediatric; sepsis; susceptibility

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

CHILD CARE; CLINICAL FEATURE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FLUID RETENTION; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INCIDENCE; INFECTION; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; PATIENT MONITORING; REVIEW; SEPSIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FLUID THERAPY; HUMANS; INFANT; INFANT, NEWBORN; MALE; RESPIRATORY SYSTEM; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 84857623305     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.163     Document Type: Review

References (23)

1. Watson RS, Carcillo JA, Linde-Zwirble WT et al. The epidemiology of severe sepsis in children in the United States. Am. J. Respir. Crit. Care Med. 167, 695-701 (2003).
2. Inwald DP, Tasker RC, Peters MJ, Nadel S; Paediatric Intensive Care Society Study Group (PICS-SG). Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch. Dis. Child. 94, 348-353 (2009).
3. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6, 2-8 (2005).
4. Zaritsky AL, Nadkarni VM, Hickey RW et al. Pediatric Advanced Life Support Provider Manual. American Heart Association, TX, USA (2002).
5. Brierley J, Carcillo JA, Choong K et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit. Care Med. 37, 666-688 (2009).
6. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378(9807), 1962-1973 (2011).
7. Beutler B, Poltorak A. Sepsis and evolution of the innate immune response. Crit. Care Med. 29, S2-S6; discussion S7 (2001).
8. Cottrill JG, Nadel S, Goldstein B. The systemic inflammatory response syndrome (SIRS), sepsis and septic shock. In: Principles and Practice of Pediatric Infectious Diseases (3rd Edition). Long SS, Pickering LK, Prober CG (Eds). Churchill Livingstone, PA, USA, 99-110 (2008).
9. Nadel S. Genetic susceptibility in sepsis: implications for the pediatric population. Paediatr. Drugs 13, 205-208 (2011).
10. Nadel S, Kroll JS. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol. Rev. 31, 71-83 (2007).
11. Wright V, Hibberd M, Levin M. Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 27(Suppl. 2), B90-B102 (2009).
12. Hibberd ML, Sumiya M, Summerfield JA et al. Association of variants of the gene for mannose binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 353, 1049-1053 (1999).
13. Davila S, Wright VJ, Khor CC et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 42, 772-776 (2010).
14. Nadel S, Newport MJ, Booy R et al. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174, 878-880 (1996).
15. Kondaveeti S, Hibberd ML, Booy R et al. Effect of the factor V leiden mutation on the severity of meningococcal disease. Pediatr. Infect. Dis. J. 18, 893-896 (1999).
16. Hermans PW, Hibberd ML, Booy R et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 354, 556-560 (1999).
17. Haralambous E, Hibberd ML, Hermans PW et al. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit. Care Med. 31, 2788-2793 (2003).
18. McCarthy MI, Abecasis GR, Cardon LR et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369 (2008).
19. Kumar A, Ellis P, Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136, 1237-1248 (2009).
20. Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin. Microbiol. Rev. 18, 657-686 (2005).
21. Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40, 1785-1791 (2005).
22. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA 266, 1242-1245 (1991).
23. Cunnington A, Nadel S. New therapies for sepsis. Curr. Top. Med. Chem. 8, 603-614 (2008).